nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Carmustine—lymphatic system cancer	0.11	0.334	CbGbCtD
Bromocriptine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0451	0.137	CbGbCtD
Bromocriptine—CYP3A4—Cytarabine—lymphatic system cancer	0.0392	0.12	CbGbCtD
Bromocriptine—CYP3A4—Teniposide—lymphatic system cancer	0.0386	0.118	CbGbCtD
Bromocriptine—ABCB1—Vincristine—lymphatic system cancer	0.031	0.0946	CbGbCtD
Bromocriptine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.027	0.0823	CbGbCtD
Bromocriptine—ABCB1—Methotrexate—lymphatic system cancer	0.0188	0.0573	CbGbCtD
Bromocriptine—CYP3A4—Vincristine—lymphatic system cancer	0.0186	0.0567	CbGbCtD
Bromocriptine—Alopecia—Teniposide—lymphatic system cancer	0.00211	0.00313	CcSEcCtD
Bromocriptine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00208	0.0031	CcSEcCtD
Bromocriptine—Visual impairment—Fludarabine—lymphatic system cancer	0.00202	0.003	CcSEcCtD
Bromocriptine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.002	0.00297	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.00199	0.00296	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00194	0.00288	CcSEcCtD
Bromocriptine—Diplopia—Carmustine—lymphatic system cancer	0.00194	0.00288	CcSEcCtD
Bromocriptine—Agitation—Teniposide—lymphatic system cancer	0.00191	0.00284	CcSEcCtD
Bromocriptine—Arrhythmia—Fludarabine—lymphatic system cancer	0.00187	0.00278	CcSEcCtD
Bromocriptine—Alopecia—Fludarabine—lymphatic system cancer	0.00185	0.00275	CcSEcCtD
Bromocriptine—Ataxia—Carmustine—lymphatic system cancer	0.00182	0.00271	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.0018	0.00268	CcSEcCtD
Bromocriptine—Hypertension—Teniposide—lymphatic system cancer	0.00179	0.00267	CcSEcCtD
Bromocriptine—Burning sensation—Methotrexate—lymphatic system cancer	0.00178	0.00265	CcSEcCtD
Bromocriptine—Urinary retention—Vincristine—lymphatic system cancer	0.00176	0.00262	CcSEcCtD
Bromocriptine—Ataxia—Vincristine—lymphatic system cancer	0.00174	0.00259	CcSEcCtD
Bromocriptine—Confusional state—Teniposide—lymphatic system cancer	0.00171	0.00254	CcSEcCtD
Bromocriptine—Oedema—Teniposide—lymphatic system cancer	0.00169	0.00252	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00169	0.00251	CcSEcCtD
Bromocriptine—Infection—Teniposide—lymphatic system cancer	0.00168	0.0025	CcSEcCtD
Bromocriptine—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00168	0.0025	CcSEcCtD
Bromocriptine—Agitation—Fludarabine—lymphatic system cancer	0.00168	0.00249	CcSEcCtD
Bromocriptine—Dysphagia—Carmustine—lymphatic system cancer	0.00168	0.00249	CcSEcCtD
Bromocriptine—Tachycardia—Teniposide—lymphatic system cancer	0.00165	0.00246	CcSEcCtD
Bromocriptine—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00165	0.00245	CcSEcCtD
Bromocriptine—Pleural effusion—Methotrexate—lymphatic system cancer	0.00161	0.0024	CcSEcCtD
Bromocriptine—Anorexia—Teniposide—lymphatic system cancer	0.00161	0.0024	CcSEcCtD
Bromocriptine—Hypotension—Teniposide—lymphatic system cancer	0.00158	0.00235	CcSEcCtD
Bromocriptine—Convulsion—Fludarabine—lymphatic system cancer	0.00158	0.00235	CcSEcCtD
Bromocriptine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00157	0.00234	CcSEcCtD
Bromocriptine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00153	0.00227	CcSEcCtD
Bromocriptine—Dyspnoea—Teniposide—lymphatic system cancer	0.00151	0.00225	CcSEcCtD
Bromocriptine—Confusional state—Fludarabine—lymphatic system cancer	0.0015	0.00223	CcSEcCtD
Bromocriptine—Oedema—Fludarabine—lymphatic system cancer	0.00149	0.00221	CcSEcCtD
Bromocriptine—Infection—Fludarabine—lymphatic system cancer	0.00148	0.0022	CcSEcCtD
Bromocriptine—Decreased appetite—Teniposide—lymphatic system cancer	0.00147	0.00219	CcSEcCtD
Bromocriptine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00146	0.00217	CcSEcCtD
Bromocriptine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00146	0.00217	CcSEcCtD
Bromocriptine—Rash—Mechlorethamine—lymphatic system cancer	0.00145	0.00216	CcSEcCtD
Bromocriptine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00145	0.00215	CcSEcCtD
Bromocriptine—Anorexia—Fludarabine—lymphatic system cancer	0.00142	0.00211	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00141	0.00209	CcSEcCtD
Bromocriptine—Myocardial infarction—Vincristine—lymphatic system cancer	0.0014	0.00208	CcSEcCtD
Bromocriptine—Feeling abnormal—Teniposide—lymphatic system cancer	0.0014	0.00208	CcSEcCtD
Bromocriptine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00139	0.00207	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00138	0.00206	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00137	0.00204	CcSEcCtD
Bromocriptine—Nausea—Mechlorethamine—lymphatic system cancer	0.00136	0.00203	CcSEcCtD
Bromocriptine—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00136	0.00203	CcSEcCtD
Bromocriptine—Alopecia—Bleomycin—lymphatic system cancer	0.00136	0.00202	CcSEcCtD
Bromocriptine—Urticaria—Teniposide—lymphatic system cancer	0.00135	0.002	CcSEcCtD
Bromocriptine—Body temperature increased—Teniposide—lymphatic system cancer	0.00134	0.00199	CcSEcCtD
Bromocriptine—Abdominal pain—Teniposide—lymphatic system cancer	0.00134	0.00199	CcSEcCtD
Bromocriptine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00134	0.00199	CcSEcCtD
Bromocriptine—Hallucination—Carmustine—lymphatic system cancer	0.00133	0.00199	CcSEcCtD
Bromocriptine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00133	0.00199	CcSEcCtD
Bromocriptine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00133	0.00197	CcSEcCtD
Bromocriptine—Oedema peripheral—Carmustine—lymphatic system cancer	0.00132	0.00197	CcSEcCtD
Bromocriptine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00132	0.00196	CcSEcCtD
Bromocriptine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00131	0.00195	CcSEcCtD
Bromocriptine—Sinusitis—Mitoxantrone—lymphatic system cancer	0.0013	0.00194	CcSEcCtD
Bromocriptine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00129	0.00193	CcSEcCtD
Bromocriptine—Visual impairment—Carmustine—lymphatic system cancer	0.00129	0.00192	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00128	0.00191	CcSEcCtD
Bromocriptine—Fatigue—Fludarabine—lymphatic system cancer	0.00128	0.00191	CcSEcCtD
Bromocriptine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00127	0.0019	CcSEcCtD
Bromocriptine—Hallucination—Vincristine—lymphatic system cancer	0.00127	0.0019	CcSEcCtD
Bromocriptine—Constipation—Fludarabine—lymphatic system cancer	0.00127	0.00189	CcSEcCtD
Bromocriptine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00127	0.00189	CcSEcCtD
Bromocriptine—Vasculitis—Methotrexate—lymphatic system cancer	0.00127	0.00189	CcSEcCtD
Bromocriptine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00126	0.00187	CcSEcCtD
Bromocriptine—Eye disorder—Carmustine—lymphatic system cancer	0.00125	0.00186	CcSEcCtD
Bromocriptine—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00125	0.00186	CcSEcCtD
Bromocriptine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00123	0.00183	CcSEcCtD
Bromocriptine—Asthenia—Teniposide—lymphatic system cancer	0.00122	0.00181	CcSEcCtD
Bromocriptine—Arrhythmia—Carmustine—lymphatic system cancer	0.0012	0.00178	CcSEcCtD
Bromocriptine—Cardiac disorder—Vincristine—lymphatic system cancer	0.00119	0.00177	CcSEcCtD
Bromocriptine—Alopecia—Carmustine—lymphatic system cancer	0.00118	0.00176	CcSEcCtD
Bromocriptine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00118	0.00175	CcSEcCtD
Bromocriptine—Mental disorder—Carmustine—lymphatic system cancer	0.00117	0.00175	CcSEcCtD
Bromocriptine—Angiopathy—Vincristine—lymphatic system cancer	0.00116	0.00173	CcSEcCtD
Bromocriptine—Diarrhoea—Teniposide—lymphatic system cancer	0.00116	0.00172	CcSEcCtD
Bromocriptine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00115	0.00172	CcSEcCtD
Bromocriptine—Alopecia—Vincristine—lymphatic system cancer	0.00113	0.00168	CcSEcCtD
Bromocriptine—Mental disorder—Vincristine—lymphatic system cancer	0.00112	0.00167	CcSEcCtD
Bromocriptine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00111	0.00166	CcSEcCtD
Bromocriptine—Alopecia—Mitoxantrone—lymphatic system cancer	0.0011	0.00164	CcSEcCtD
Bromocriptine—Confusional state—Bleomycin—lymphatic system cancer	0.0011	0.00164	CcSEcCtD
Bromocriptine—Vision blurred—Carmustine—lymphatic system cancer	0.0011	0.00164	CcSEcCtD
Bromocriptine—Oedema—Bleomycin—lymphatic system cancer	0.00109	0.00162	CcSEcCtD
Bromocriptine—Infection—Bleomycin—lymphatic system cancer	0.00108	0.00161	CcSEcCtD
Bromocriptine—Vomiting—Teniposide—lymphatic system cancer	0.00108	0.0016	CcSEcCtD
Bromocriptine—Agitation—Carmustine—lymphatic system cancer	0.00107	0.0016	CcSEcCtD
Bromocriptine—Asthenia—Fludarabine—lymphatic system cancer	0.00107	0.00159	CcSEcCtD
Bromocriptine—Rash—Teniposide—lymphatic system cancer	0.00107	0.00159	CcSEcCtD
Bromocriptine—Dermatitis—Teniposide—lymphatic system cancer	0.00107	0.00159	CcSEcCtD
Bromocriptine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00106	0.00158	CcSEcCtD
Bromocriptine—Headache—Teniposide—lymphatic system cancer	0.00106	0.00158	CcSEcCtD
Bromocriptine—Anorexia—Bleomycin—lymphatic system cancer	0.00104	0.00155	CcSEcCtD
Bromocriptine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00103	0.00154	CcSEcCtD
Bromocriptine—Agitation—Vincristine—lymphatic system cancer	0.00102	0.00152	CcSEcCtD
Bromocriptine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00102	0.00152	CcSEcCtD
Bromocriptine—Hypotension—Bleomycin—lymphatic system cancer	0.00102	0.00152	CcSEcCtD
Bromocriptine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00102	0.00152	CcSEcCtD
Bromocriptine—Convulsion—Carmustine—lymphatic system cancer	0.00101	0.0015	CcSEcCtD
Bromocriptine—Hypertension—Carmustine—lymphatic system cancer	0.00101	0.0015	CcSEcCtD
Bromocriptine—Nausea—Teniposide—lymphatic system cancer	0.00101	0.0015	CcSEcCtD
Bromocriptine—Vertigo—Vincristine—lymphatic system cancer	0.001	0.00149	CcSEcCtD
Bromocriptine—Anxiety—Carmustine—lymphatic system cancer	0.00099	0.00147	CcSEcCtD
Bromocriptine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00098	0.00146	CcSEcCtD
Bromocriptine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000973	0.00145	CcSEcCtD
Bromocriptine—Convulsion—Vincristine—lymphatic system cancer	0.000965	0.00144	CcSEcCtD
Bromocriptine—Hypertension—Vincristine—lymphatic system cancer	0.000962	0.00143	CcSEcCtD
Bromocriptine—Confusional state—Carmustine—lymphatic system cancer	0.00096	0.00143	CcSEcCtD
Bromocriptine—Oedema—Carmustine—lymphatic system cancer	0.000953	0.00142	CcSEcCtD
Bromocriptine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000949	0.00141	CcSEcCtD
Bromocriptine—Visual disturbance—Methotrexate—lymphatic system cancer	0.000947	0.00141	CcSEcCtD
Bromocriptine—Infection—Carmustine—lymphatic system cancer	0.000946	0.00141	CcSEcCtD
Bromocriptine—Vomiting—Fludarabine—lymphatic system cancer	0.000946	0.00141	CcSEcCtD
Bromocriptine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00094	0.0014	CcSEcCtD
Bromocriptine—Rash—Fludarabine—lymphatic system cancer	0.000938	0.0014	CcSEcCtD
Bromocriptine—Dermatitis—Fludarabine—lymphatic system cancer	0.000938	0.0014	CcSEcCtD
Bromocriptine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000937	0.00139	CcSEcCtD
Bromocriptine—Headache—Fludarabine—lymphatic system cancer	0.000932	0.00139	CcSEcCtD
Bromocriptine—Tachycardia—Carmustine—lymphatic system cancer	0.00093	0.00138	CcSEcCtD
Bromocriptine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000921	0.00137	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000916	0.00136	CcSEcCtD
Bromocriptine—Lethargy—Methotrexate—lymphatic system cancer	0.000916	0.00136	CcSEcCtD
Bromocriptine—Oedema—Vincristine—lymphatic system cancer	0.000909	0.00135	CcSEcCtD
Bromocriptine—Anorexia—Carmustine—lymphatic system cancer	0.000908	0.00135	CcSEcCtD
Bromocriptine—Infection—Vincristine—lymphatic system cancer	0.000903	0.00134	CcSEcCtD
Bromocriptine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000899	0.00134	CcSEcCtD
Bromocriptine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000893	0.00133	CcSEcCtD
Bromocriptine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000892	0.00133	CcSEcCtD
Bromocriptine—Hypotension—Carmustine—lymphatic system cancer	0.00089	0.00132	CcSEcCtD
Bromocriptine—Oedema—Mitoxantrone—lymphatic system cancer	0.000886	0.00132	CcSEcCtD
Bromocriptine—Nausea—Fludarabine—lymphatic system cancer	0.000884	0.00132	CcSEcCtD
Bromocriptine—Infection—Mitoxantrone—lymphatic system cancer	0.00088	0.00131	CcSEcCtD
Bromocriptine—Shock—Mitoxantrone—lymphatic system cancer	0.000871	0.0013	CcSEcCtD
Bromocriptine—Urticaria—Bleomycin—lymphatic system cancer	0.000867	0.00129	CcSEcCtD
Bromocriptine—Anorexia—Vincristine—lymphatic system cancer	0.000867	0.00129	CcSEcCtD
Bromocriptine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000864	0.00129	CcSEcCtD
Bromocriptine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000863	0.00128	CcSEcCtD
Bromocriptine—Insomnia—Carmustine—lymphatic system cancer	0.000862	0.00128	CcSEcCtD
Bromocriptine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00086	0.00128	CcSEcCtD
Bromocriptine—Paraesthesia—Carmustine—lymphatic system cancer	0.000855	0.00127	CcSEcCtD
Bromocriptine—Hypotension—Vincristine—lymphatic system cancer	0.00085	0.00126	CcSEcCtD
Bromocriptine—Dyspnoea—Carmustine—lymphatic system cancer	0.000849	0.00126	CcSEcCtD
Bromocriptine—Somnolence—Carmustine—lymphatic system cancer	0.000847	0.00126	CcSEcCtD
Bromocriptine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000844	0.00126	CcSEcCtD
Bromocriptine—Ataxia—Methotrexate—lymphatic system cancer	0.000844	0.00126	CcSEcCtD
Bromocriptine—Decreased appetite—Carmustine—lymphatic system cancer	0.000828	0.00123	CcSEcCtD
Bromocriptine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000828	0.00123	CcSEcCtD
Bromocriptine—Insomnia—Vincristine—lymphatic system cancer	0.000822	0.00122	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000822	0.00122	CcSEcCtD
Bromocriptine—Paraesthesia—Vincristine—lymphatic system cancer	0.000817	0.00122	CcSEcCtD
Bromocriptine—Constipation—Carmustine—lymphatic system cancer	0.000815	0.00121	CcSEcCtD
Bromocriptine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000795	0.00118	CcSEcCtD
Bromocriptine—Decreased appetite—Vincristine—lymphatic system cancer	0.00079	0.00118	CcSEcCtD
Bromocriptine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00079	0.00117	CcSEcCtD
Bromocriptine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000787	0.00117	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000785	0.00117	CcSEcCtD
Bromocriptine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000785	0.00117	CcSEcCtD
Bromocriptine—Fatigue—Vincristine—lymphatic system cancer	0.000784	0.00117	CcSEcCtD
Bromocriptine—Asthenia—Bleomycin—lymphatic system cancer	0.000783	0.00117	CcSEcCtD
Bromocriptine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00078	0.00116	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000779	0.00116	CcSEcCtD
Bromocriptine—Constipation—Vincristine—lymphatic system cancer	0.000778	0.00116	CcSEcCtD
Bromocriptine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00077	0.00115	CcSEcCtD
Bromocriptine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000763	0.00114	CcSEcCtD
Bromocriptine—Constipation—Mitoxantrone—lymphatic system cancer	0.000757	0.00113	CcSEcCtD
Bromocriptine—Abdominal pain—Carmustine—lymphatic system cancer	0.000753	0.00112	CcSEcCtD
Bromocriptine—Body temperature increased—Carmustine—lymphatic system cancer	0.000753	0.00112	CcSEcCtD
Bromocriptine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000744	0.00111	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000744	0.00111	CcSEcCtD
Bromocriptine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00073	0.00109	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000724	0.00108	CcSEcCtD
Bromocriptine—Abdominal pain—Vincristine—lymphatic system cancer	0.000719	0.00107	CcSEcCtD
Bromocriptine—Body temperature increased—Vincristine—lymphatic system cancer	0.000719	0.00107	CcSEcCtD
Bromocriptine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000704	0.00105	CcSEcCtD
Bromocriptine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.0007	0.00104	CcSEcCtD
Bromocriptine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0007	0.00104	CcSEcCtD
Bromocriptine—Vomiting—Bleomycin—lymphatic system cancer	0.000694	0.00103	CcSEcCtD
Bromocriptine—Drowsiness—Methotrexate—lymphatic system cancer	0.000692	0.00103	CcSEcCtD
Bromocriptine—Rash—Bleomycin—lymphatic system cancer	0.000688	0.00102	CcSEcCtD
Bromocriptine—Dermatitis—Bleomycin—lymphatic system cancer	0.000687	0.00102	CcSEcCtD
Bromocriptine—Asthenia—Carmustine—lymphatic system cancer	0.000683	0.00102	CcSEcCtD
Bromocriptine—Asthenia—Vincristine—lymphatic system cancer	0.000652	0.000971	CcSEcCtD
Bromocriptine—Diarrhoea—Carmustine—lymphatic system cancer	0.000652	0.00097	CcSEcCtD
Bromocriptine—Nausea—Bleomycin—lymphatic system cancer	0.000648	0.000965	CcSEcCtD
Bromocriptine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000635	0.000945	CcSEcCtD
Bromocriptine—Dizziness—Carmustine—lymphatic system cancer	0.00063	0.000937	CcSEcCtD
Bromocriptine—Diarrhoea—Vincristine—lymphatic system cancer	0.000622	0.000926	CcSEcCtD
Bromocriptine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000606	0.000902	CcSEcCtD
Bromocriptine—Vomiting—Carmustine—lymphatic system cancer	0.000606	0.000901	CcSEcCtD
Bromocriptine—Dizziness—Vincristine—lymphatic system cancer	0.000601	0.000895	CcSEcCtD
Bromocriptine—Rash—Carmustine—lymphatic system cancer	0.000601	0.000894	CcSEcCtD
Bromocriptine—Dermatitis—Carmustine—lymphatic system cancer	0.0006	0.000893	CcSEcCtD
Bromocriptine—Visual impairment—Methotrexate—lymphatic system cancer	0.000598	0.000891	CcSEcCtD
Bromocriptine—Headache—Carmustine—lymphatic system cancer	0.000597	0.000888	CcSEcCtD
Bromocriptine—Eye disorder—Methotrexate—lymphatic system cancer	0.00058	0.000864	CcSEcCtD
Bromocriptine—Tinnitus—Methotrexate—lymphatic system cancer	0.000579	0.000862	CcSEcCtD
Bromocriptine—Vomiting—Vincristine—lymphatic system cancer	0.000578	0.00086	CcSEcCtD
Bromocriptine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000576	0.000858	CcSEcCtD
Bromocriptine—Rash—Vincristine—lymphatic system cancer	0.000573	0.000853	CcSEcCtD
Bromocriptine—Dermatitis—Vincristine—lymphatic system cancer	0.000573	0.000852	CcSEcCtD
Bromocriptine—Headache—Vincristine—lymphatic system cancer	0.00057	0.000848	CcSEcCtD
Bromocriptine—Nausea—Carmustine—lymphatic system cancer	0.000566	0.000842	CcSEcCtD
Bromocriptine—Angiopathy—Methotrexate—lymphatic system cancer	0.000563	0.000838	CcSEcCtD
Bromocriptine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000563	0.000838	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00056	0.000833	CcSEcCtD
Bromocriptine—Rash—Mitoxantrone—lymphatic system cancer	0.000558	0.000831	CcSEcCtD
Bromocriptine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000558	0.00083	CcSEcCtD
Bromocriptine—Headache—Mitoxantrone—lymphatic system cancer	0.000555	0.000826	CcSEcCtD
Bromocriptine—Alopecia—Methotrexate—lymphatic system cancer	0.000549	0.000817	CcSEcCtD
Bromocriptine—Mental disorder—Methotrexate—lymphatic system cancer	0.000544	0.00081	CcSEcCtD
Bromocriptine—Nausea—Vincristine—lymphatic system cancer	0.00054	0.000804	CcSEcCtD
Bromocriptine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000529	0.000788	CcSEcCtD
Bromocriptine—Nausea—Mitoxantrone—lymphatic system cancer	0.000526	0.000783	CcSEcCtD
Bromocriptine—Vision blurred—Methotrexate—lymphatic system cancer	0.00051	0.000758	CcSEcCtD
Bromocriptine—Vertigo—Methotrexate—lymphatic system cancer	0.000486	0.000723	CcSEcCtD
Bromocriptine—Convulsion—Methotrexate—lymphatic system cancer	0.000468	0.000697	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000457	0.00068	CcSEcCtD
Bromocriptine—Confusional state—Methotrexate—lymphatic system cancer	0.000445	0.000662	CcSEcCtD
Bromocriptine—Infection—Methotrexate—lymphatic system cancer	0.000438	0.000652	CcSEcCtD
Bromocriptine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000433	0.000644	CcSEcCtD
Bromocriptine—Skin disorder—Methotrexate—lymphatic system cancer	0.000429	0.000638	CcSEcCtD
Bromocriptine—Anorexia—Methotrexate—lymphatic system cancer	0.000421	0.000626	CcSEcCtD
Bromocriptine—Hypotension—Methotrexate—lymphatic system cancer	0.000412	0.000614	CcSEcCtD
Bromocriptine—Insomnia—Methotrexate—lymphatic system cancer	0.000399	0.000594	CcSEcCtD
Bromocriptine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000396	0.00059	CcSEcCtD
Bromocriptine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000393	0.000585	CcSEcCtD
Bromocriptine—Somnolence—Methotrexate—lymphatic system cancer	0.000392	0.000584	CcSEcCtD
Bromocriptine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000388	0.000578	CcSEcCtD
Bromocriptine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000384	0.000571	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000381	0.000567	CcSEcCtD
Bromocriptine—Fatigue—Methotrexate—lymphatic system cancer	0.00038	0.000566	CcSEcCtD
Bromocriptine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000364	0.000541	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000361	0.000537	CcSEcCtD
Bromocriptine—Urticaria—Methotrexate—lymphatic system cancer	0.000351	0.000522	CcSEcCtD
Bromocriptine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000349	0.000519	CcSEcCtD
Bromocriptine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000349	0.000519	CcSEcCtD
Bromocriptine—Asthenia—Methotrexate—lymphatic system cancer	0.000317	0.000471	CcSEcCtD
Bromocriptine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000302	0.000449	CcSEcCtD
Bromocriptine—Dizziness—Methotrexate—lymphatic system cancer	0.000292	0.000434	CcSEcCtD
Bromocriptine—Vomiting—Methotrexate—lymphatic system cancer	0.000281	0.000417	CcSEcCtD
Bromocriptine—Rash—Methotrexate—lymphatic system cancer	0.000278	0.000414	CcSEcCtD
Bromocriptine—Dermatitis—Methotrexate—lymphatic system cancer	0.000278	0.000414	CcSEcCtD
Bromocriptine—Headache—Methotrexate—lymphatic system cancer	0.000276	0.000411	CcSEcCtD
Bromocriptine—Nausea—Methotrexate—lymphatic system cancer	0.000262	0.00039	CcSEcCtD
